2020 update of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGHTG) on the position statement of the ÖKG and ÖGHTG for transcatheter aortic valve implantation 2011.
Aortic stenosis
Heart team
Interventional expertise
Perioperative risk
TAVI
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
06
06
2020
accepted:
21
01
2021
pubmed:
24
3
2021
medline:
21
8
2021
entrez:
23
3
2021
Statut:
ppublish
Résumé
This position statement is an update to the 2011 consensus statement of the Austrian Society of Cardiology (ÖKG) and the Austrian Society of Cardiac Surgery (ÖGTHG) for transfemoral transcatheter aortic valve implantation.Due to a number of recently published studies, broadening of indications and recommendations of medical societies and our own national developments, the ÖKG and the ÖGHTG wish to combine the 2017 ESC/EACTS guidelines for the management of valvular heart disease with a national position paper and to focus on certain details for the application in Austria. Thus, this position statement serves as a supplement and further interpretation of the international guidelines.
Identifiants
pubmed: 33755758
doi: 10.1007/s00508-021-01820-3
pii: 10.1007/s00508-021-01820-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
750-761Informations de copyright
© 2021. Springer-Verlag GmbH, AT part of Springer Nature.
Références
Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–91.
pubmed: 28886619
doi: 10.1093/eurheartj/ehx391
Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.
pubmed: 27040324
doi: 10.1056/NEJMoa1514616
Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Sondergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–31.
pubmed: 28304219
doi: 10.1056/NEJMoa1700456
Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25.
pubmed: 27053442
doi: 10.1016/S0140-6736(16)30073-3
Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799–809.
pubmed: 31995682
doi: 10.1056/NEJMoa1910555
Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.
pubmed: 30883058
doi: 10.1056/NEJMoa1814052
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15.
pubmed: 30883053
doi: 10.1056/NEJMoa1816885
Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016;31:3–10.
pubmed: 27039014
doi: 10.1016/j.ejim.2016.03.007
Makkar RR, Jilaihawi H, Mack M, Chakravarty T, Cohen DJ, Cheng W, et al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J Am Coll Cardiol. 2014;63:901–11.
pubmed: 24161334
doi: 10.1016/j.jacc.2013.08.1641
Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142–7.
pubmed: 10403851
doi: 10.1056/NEJM199907153410302
Beach JM, Mihaljevic T, Svensson LG, Rajeswaran J, Marwick T, Griffin B, et al. Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2013;61:837–48.
pubmed: 23428216
pmcid: 4262244
doi: 10.1016/j.jacc.2012.10.049
Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in sudden late death by concomitant revascularization with aortic valve replacement. J Thorac Cardiovasc Surg. 1988;95:390–401.
pubmed: 3343849
doi: 10.1016/S0022-5223(19)35758-7
Goel SS, Agarwal S, Tuzcu EM, Ellis SG, Svensson LG, Zaman T, et al. Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacement. Circulation. 2012;125:1005–13.
pubmed: 22282327
doi: 10.1161/CIRCULATIONAHA.111.039180
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.
pubmed: 20961243
doi: 10.1056/NEJMoa1008232
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.
pubmed: 21639811
doi: 10.1056/NEJMoa1103510
Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705–15.
pubmed: 22551129
doi: 10.1056/NEJMoa1114705
pmcid: 22551129
Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochelliere R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63:2643–58.
pubmed: 24681140
doi: 10.1016/j.jacc.2014.02.573
pmcid: 24681140
Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9.
pubmed: 23578349
doi: 10.1016/j.amjcard.2013.03.024
pmcid: 23578349
Chakravarty T, Van Belle E, Jilaihawi H, Noheria A, Testa L, Bedogni F, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015;115:942–9.
pubmed: 25779617
doi: 10.1016/j.amjcard.2015.01.022
Diaz R, Hernandez-Vaquero D, Alvarez-Cabo R, Avanzas P, Silva J, Moris C, et al. Long-term outcomes of mechanical versus biological aortic valve prosthesis: systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2019;158:706–714.e18.
pubmed: 30579533
doi: 10.1016/j.jtcvs.2018.10.146
Puskas JD, Gerdisch M, Nichols D, Fermin L, Rhenman B, Kapoor D, et al. Anticoagulation and antiplatelet strategies after on‑X mechanical aortic valve replacement. J Am Coll Cardiol. 2018;71:2717–26.
pubmed: 29903344
doi: 10.1016/j.jacc.2018.03.535
Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. 3‑year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2565–74.
pubmed: 27050187
doi: 10.1016/j.jacc.2016.03.506
Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84.
pubmed: 25788234
doi: 10.1016/S0140-6736(15)60308-7
Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv. 2016;9(6):e3665.
pubmed: 27296202
doi: 10.1161/CIRCINTERVENTIONS.115.003665
Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1‑year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–94.
pubmed: 25787196
doi: 10.1016/j.jacc.2015.03.014
Sondergaard L, Ihlemann N, Capodanno D, Jorgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73:546–53.
pubmed: 30732707
doi: 10.1016/j.jacc.2018.10.083
Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2485–91.
pubmed: 25788231
doi: 10.1016/S0140-6736(15)60290-2
Siemieniuk RA, Agoritsas T, Manja V, Devji T, Chang Y, Bala MM, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis. BMJ. 2016;354:i5130.
pubmed: 27683246
pmcid: 5040923
doi: 10.1136/bmj.i5130
Vandvik PO, Otto CM, Siemieniuk RA, Bagur R, Guyatt GH, Lytvyn L, et al. Transcatheter or surgical aortic valve replacement for patients with severe, symptomatic, aortic stenosis at low to intermediate surgical risk: a clinical practice guideline. BMJ. 2016;354:i5085.
pubmed: 27680583
doi: 10.1136/bmj.i5085
Carroll JD, Vemulapalli S, Dai D, Matsouaka R, Blackstone E, Edwards F, et al. Procedural experience for transcatheter aortic valve replacement and relation to outcomes: the STS/ACC TVT registry. J Am Coll Cardiol. 2017;70:29–41.
pubmed: 28662805
doi: 10.1016/j.jacc.2017.04.056
Wassef AWA, Rodes-Cabau J, Liu Y, Webb JG, Barbanti M, Munoz-Garcia AJ, et al. The learning curve and annual procedure volume standards for optimum outcomes of transcatheter aortic valve replacement: findings from an international registry. JACC Cardiovasc Interv. 2018;11:1669–79.
pubmed: 30190058
doi: 10.1016/j.jcin.2018.06.044
Vemulapalli S, Carroll JD, Mack MJ, Li Z, Dai D, Kosinski AS, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N Engl J Med. 2019; https://doi.org/10.1056/NEJMsa1901109 .
doi: 10.1056/NEJMsa1901109
pubmed: 31577892
Bestehorn K, Eggebrecht H, Fleck E, Bestehorn M, Mehta RH, Kuck KH. Volume-outcome relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German quality assurance registry on aortic valve replacement (AQUA). EuroIntervention. 2017;13:914–20.
pubmed: 28590248
doi: 10.4244/EIJ-D-17-00062
Inohara T, Hayashida K, Watanabe Y, Yamamoto M, Takagi K, Yashima F, et al. Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries. Catheter Cardiovasc Interv. 2016;87:963–70.
pubmed: 26489980
doi: 10.1002/ccd.26266
Eggebrecht H, Bestehorn M, Haude M, Schmermund A, Bestehorn K, Voigtlander T, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J. 2016;37:2240–8.
pubmed: 27190093
doi: 10.1093/eurheartj/ehw190
Eggebrecht H, Schmermund A. The current situation and the future of emergent cardiac surgery in TAVI. Interv Cardiol. 2015;10:55–7.
pubmed: 29588675
pmcid: 5808467
doi: 10.15420/icr.2015.10.1.55
Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M, et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv. 2012;5:424–32.
pubmed: 22589295
doi: 10.1161/CIRCINTERVENTIONS.111.967315
pmcid: 22589295
Hamm CW, Mollmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, et al. The German aortic valve registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.
pubmed: 24022003
doi: 10.1093/eurheartj/eht381
pmcid: 24022003
Egger F, Zweiker D, Freynhofer MK, Loffler V, Rohla M, Geppert A, et al. Impact of on-site cardiac surgery on clinical outcomes after transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:2160–7.
pubmed: 30409272
doi: 10.1016/j.jcin.2018.07.015
pmcid: 30409272
Babaliaros V, Devireddy C, Lerakis S, Leonardi R, Iturra SA, Mavromatis K, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7:898–904.
pubmed: 25086843
doi: 10.1016/j.jcin.2014.04.005
Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Ringsred K, et al. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018;19:192–5.
pubmed: 28923694
doi: 10.1016/j.carrev.2017.08.002
Spaziano M, Lefevre T, Romano M, Eltchaninoff H, Leprince P, Motreff P, et al. Transcatheter aortic valve replacement in the catheterization laboratory versus hybrid operating room: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:2195–203.
pubmed: 30409276
doi: 10.1016/j.jcin.2018.06.043
Deharo P, Jaussaud N, Grisoli D, Camus O, Resseguier N, Le Breton H, et al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry. JACC Cardiovasc Interv. 2018;11:1956–65.
pubmed: 30219324
doi: 10.1016/j.jcin.2018.06.023
Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, et al. The electrocardiogram after transcatheter aortic valve replacement determines the risk for post-procedural high-degree AV block and the need for telemetry monitoring. JACC Cardiovasc Interv. 2016;9:1269–76.
pubmed: 27339844
doi: 10.1016/j.jcin.2016.03.024
Brouwer J, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020; https://doi.org/10.1056/NEJMoa2017815 .
doi: 10.1056/NEJMoa2017815
pubmed: 32865376
von Scheidt W, et al. Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : joint consensus document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e. V. (ALKK) and cooperating cardiac surgery department. Clin Res Cardiol. 2020;109:1–12.
doi: 10.1007/s00392-019-01528-5
Otto C, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2020; https://doi.org/10.1016/j.jacc.2020.11.018 .
doi: 10.1016/j.jacc.2020.11.018
pubmed: 33342587
pmcid: 7755038
Lamm G. New strategies in the management of valvular heart disease. Wien Klin Wochenschr. 2021. (submitted)